(FixThisNation.com) – On Wednesday, President Joe Biden is going to tout the efforts of his party to bring down the cost of inhalers following the recent announcement by drug makers that they would be capping prices.
Biden along with Sen. Bernie Sanders (I-Vt.), and several health care experts are going to be giving remarks at the White House about the victory in cracking down on inhalers cost. As part of the crackdown, the administration had looked at possible anticompetitive practices that could have delayed the lower-cost generics from being made available in the market. In March, three out of the four largest inhaler manufacturers announced that they would be capping inhalers to $35 per month for many patients.
This move comes after Sanders, along with a group of Democratic Senators had addressed a letter to the CEOs of the four biggest manufacturers calling for them to provide access to information regarding the costs of manufacturing inhalers, among a number of other issues. The letter was sent to Teva, GlaxoSmithKline, Boehringer Ingelheim, and AstraZeneca.
At the time of the letter, AstraZeneca’s one inhaler cost $645 in the United States, while in the United Kingdom, the same product had cost $49. The recent announcement would cap the out-of-pocket cost to $35 for inhaler products by AstraZeneca. A similar move is also introduced by Boehringer Ingelheim.
On Wednesday Biden is going to focus his remarks on the efforts from the Inflation Reduction Act, which was only supported by the Democrats, and was focused on bringing down the cost of prescription medication, and medication for seniors on Medicare.
Copyright 2024, FixThisNation.com
